CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 684

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 15.75%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57%
Services
Technology
Transportation
Utilities

43 Activity Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
RECEPTOS INC COM 93,761 -15,617 (14.28) 641,800
PUMA BIOTECHNOLOGY INC COM 39,259 -51,304 (56.65) 220,000
NEUROCRINE BIOSCIENCES INC COM 35,610 5,342 17.65 1,000,000
CELGENE CORP COM 32,262 32,262 New 300,000
ALKERMES PLC SHS 25,083 19,509 350 450,000
PORTOLA PHARMACEUTICALS INC COM 21,714 14,476 200 600,000
OVASCIENCE INC COM 18,279 5,648 44.71 747,000
SORRENTO THERAPEUTICS INC COM NEW 18,218 7,808 75 1,750,000
BRISTOL MYERS SQUIBB CO COM 16,258 6,503 66.67 250,000
QUOTIENT LTD SHS 15,840 8,640 120 1,100,000
ADVAXIS INC COM NEW 14,826 8,645 139.86 839,500
REGULUS THERAPEUTICS INC COM 14,036 11,484 450 1,100,000
CHIMERIX INC COM 13,964 5,237 60 400,000
KITE PHARMA INC COM 13,711 8,334 155 255,000
OMEROS CORP COM 12,094 714 6.28 582,300
ARDELYX INC COM 11,494 7,253 171.03 1,053,500
CHINA BIOLOGIC PRODS INC COM 8,863 -492 (5.26) 90,000
BIOCRYST PHARMACEUTICALS COM 7,408 -2,778 (27.27) 800,000
ALDER BIOPHARMACEUTICALS INC COM 6,790 2,716 66.67 250,000
ACCELERON PHARMA INC COM 6,780 -4,068 (37.5) 250,000